These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 3680266)

  • 41. Studies on the binding and degradation of human very-low-density lipoproteins by human hepatoma cell line HepG2.
    Dashti N; Wolfbauer G
    Biochim Biophys Acta; 1986 Feb; 875(3):473-86. PubMed ID: 3004589
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins.
    Trieu VN; Zioncheck TF; Lawn RM; McConathy WJ
    J Biol Chem; 1991 Mar; 266(9):5480-5. PubMed ID: 1848551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors.
    Hui DY; Innerarity TL; Mahley RW
    J Biol Chem; 1981 Jun; 256(11):5646-55. PubMed ID: 6263887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype.
    Guo HC; Chapman MJ; Bruckert E; Farriaux JP; De Gennes JL
    Atherosclerosis; 1991 Jan; 86(1):69-83. PubMed ID: 1829609
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
    Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
    Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).
    Chappell DA
    J Clin Invest; 1989 Dec; 84(6):1906-15. PubMed ID: 2556448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of a critical lysine residue in apolipoprotein B-100 that mediates noncovalent interaction with apolipoprotein(a).
    Becker L; McLeod RS; Marcovina SM; Yao Z; Koschinsky ML
    J Biol Chem; 2001 Sep; 276(39):36155-62. PubMed ID: 11473115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).
    Linton MF; Farese RV; Chiesa G; Grass DS; Chin P; Hammer RE; Hobbs HH; Young SG
    J Clin Invest; 1993 Dec; 92(6):3029-37. PubMed ID: 8254057
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of human apolipoprotein B90 in transgenic mice. Demonstration that apolipoprotein B90 lacks the structural requirements to form lipoprotein.
    McCormick SP; Linton MF; Hobbs HH; Taylor S; Curtiss LK; Young SG
    J Biol Chem; 1994 Sep; 269(39):24284-9. PubMed ID: 7929084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lipoprotein(a) mediates high affinity low density lipoprotein association to receptor negative fibroblasts.
    Kostner GM; Grillhofer HK
    J Biol Chem; 1991 Nov; 266(31):21287-92. PubMed ID: 1834657
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heterogeneity of human lipoprotein Lp[a]: cytochemical and biochemical studies on the interaction of two Lp[a] species with the LDL receptor.
    Armstrong VW; Harrach B; Robenek H; Helmhold M; Walli AK; Seidel D
    J Lipid Res; 1990 Mar; 31(3):429-41. PubMed ID: 2140397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A 13C NMR characterization of lysine residues in apolipoprotein B and their role in binding to the low density lipoprotein receptor.
    Lund-Katz S; Ibdah JA; Letizia JY; Thomas MT; Phillips MC
    J Biol Chem; 1988 Sep; 263(27):13831-8. PubMed ID: 3138240
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lipoprotein(a) and apolipoprotein(a) in a New World monkey, the common marmoset (Callithrix jacchus). Association of variable plasma lipoprotein(a) levels with a single apolipoprotein(a) isoform.
    Guo HC; Michel JB; Blouquit Y; Chapman MJ
    Arterioscler Thromb; 1991; 11(4):1030-41. PubMed ID: 1829630
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100.
    Véniant MM; Sullivan MA; Kim SK; Ambroziak P; Chu A; Wilson MD; Hellerstein MK; Rudel LL; Walzem RL; Young SG
    J Clin Invest; 2000 Dec; 106(12):1501-10. PubMed ID: 11120757
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of defective binding of low density lipoprotein by the U937 proliferation assay in German patients with familial defective apolipoprotein B-100.
    Schewe CK; Schuster H; Hailer S; Wolfram G; Keller C; Zöllner N
    Eur J Clin Invest; 1994 Jan; 24(1):36-41. PubMed ID: 8187806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heterogeneity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins.
    Fless GM; Rolih CA; Scanu AM
    J Biol Chem; 1984 Sep; 259(18):11470-8. PubMed ID: 6236225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apolipoprotein A-I and apolipoprotein B containing lipoprotein particles in coronary patients treated with extracorporal low density lipoprotein precipitation (HELP).
    Koren E; Armstrong VW; Mueller G; Wilson PR; Schuff-Werner P; Thiery J; Eisenhauer T; Alaupovic P; Seidel D
    Atherosclerosis; 1992 Aug; 95(2-3):157-70. PubMed ID: 1418090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro proteolysis of human plasma low density lipoproteins by an elastase released from human blood polymorphonuclear cells.
    Polacek D; Byrne RE; Fless GM; Scanu AM
    J Biol Chem; 1986 Feb; 261(5):2057-63. PubMed ID: 3632977
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments.
    Innerarity TL; Friedlander EJ; Rall SC; Weisgraber KH; Mahley RW
    J Biol Chem; 1983 Oct; 258(20):12341-7. PubMed ID: 6313652
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100.
    Koschinsky ML; Côté GP; Gabel B; van der Hoek YY
    J Biol Chem; 1993 Sep; 268(26):19819-25. PubMed ID: 8366120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.